KEYWORD INDEX
 |
|
| Click on the first letter of the keyword: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other |
|
|
|
|
|
|
|
|
|
|
Search results for: "M"
Results 1 - 10 of 254 shown below |
|
|
|
|
|
|
|
| m-chloro-phenylpiperazine (mCPP) |
|
| Elias Eriksson, Göran Engberg, Ola Bing and Hans Nissbrandt Effects of mCPP on the Extracellular Concentrations of Serotonin and Dopamine in Rat Brain doi:10.1016/S0893-133X(98)00070-0 Neuropsychopharmacology 20, 287-296 | Abstract | Full text | PDF | |
|
|
|
| m-Chlorophenylpiperazine |
|
| Lawrence H Price, Robert T Malison, Christopher J McDougle, Elinore F McCane-Katz, Kim R Owen and George R Heninger Neurobiology of Tryptophan Depletion in Depression: Effects of m-Chlorophenylpiperazine (mCPP) doi:10.1016/S0893-133X(97)00084-5 Neuropsychopharmacology 17, 342-350 | Abstract | PDF | |
|
|
|
| Michael H Baumann, Mario A Ayestas, Christina M Dersch and Richard B Rothman 1-(m-Chlorophenyl)piperazine (mCPP) Dissociates In Vivo Serotonin Release from Long-Term Serotonin Depletion in Rat Brain doi:10.1016/S0893-133X(00)00221-9 Neuropsychopharmacology 24, 492-501 | Abstract | Full text | PDF | |
|
|
|
| m-Chlorophenylpiperazine (m-CPP) |
|
| Tung-Ping Su, Peter J Schmidt, Merry A Danaceau, Marie B Tobin, Donald L Rosenstein, Dennis L Murphy and David R Rubinow Fluoxetine in the Treatment of Premenstrual Dysphoria doi:10.1016/S0893-133X(96)00245-X Neuropsychopharmacology 16, 346-356 | Abstract | PDF | |
|
|
|
| m-chlorophenylpiperazine (mCPP) |
|
| Neera Ghaziuddin, Kathy Welch and John Greden Central Serotonergic Effects of m-Chlorophenylpiperazine (mCPP) among Normal Control Adolescents doi:10.1038/sj.npp.1300006 Neuropsychopharmacology 28, 133-139 | Abstract | Full text | PDF | |
|
|
|
| Ilga Misane, Sven Ove Ögren and Med Sc Multiple 5-HT Receptors in Passive Avoidance: Comparative Studies of p-Chloroamphetamine and 8-OH-DPAT doi:10.1016/S0893-133X(99)00109-8 Neuropsychopharmacology 22, 168-190 | Abstract | Full text | PDF | |
|
|
|
| M1 |
|
| Chihiro Tohda, Noriaki Matsumoto, Kun Zou, Meselhy R Meselhy and Katsuko Komatsu A  (25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponinsdoi:10.1038/sj.npp.1300388 Neuropsychopharmacology 29, 860-868 | Abstract | Full text | PDF | |
|
|
|
| Chihiro Tohda, Itsuki Hashimoto, Tomoharu Kuboyama and Katsuko Komatsu Metabolite 1 of Protopanaxadiol-Type Saponins, an Axonal Regenerative Factor, Stimulates Teneurin-2 Linked by PI3-Kinase Cascade doi:10.1038/sj.npp.1300943 Neuropsychopharmacology 31, 1158-1164 | Abstract | Full text | PDF | |
|
|
|
| M1 muscarinic receptor |
|
| Nicoletta Galeotti, Alessandro Bartolini and Carla Ghelardini The Phospholipase C-IP3 Pathway is Involved in Muscarinic Antinociception doi:10.1038/sj.npp.1300111 Neuropsychopharmacology 28, 888-897 | Abstract | Full text | PDF | |
|
|
|
| M100907 |
|
| Alasdair M Barr, Virginia Lehmann-Masten, Martin Paulus, Raul R Gainetdinov, Marc G Caron and Mark A Geyer The Selective Serotonin-2A Receptor Antagonist M100907 Reverses Behavioral Deficits in Dopamine Transporter Knockout Mice doi:10.1038/sj.npp.1300343 Neuropsychopharmacology 29, 221-228 | Abstract | Full text | PDF | |
|
|
|
| Gerard J Marek, Raul Martin-Ruiz, Allyson Abo and Francesc Artigas The Selective 5-HT2A Receptor Antagonist M100907 Enhances Antidepressant-Like Behavioral Effects of the SSRI Fluoxetine doi:10.1038/sj.npp.1300762 Neuropsychopharmacology 30, 2205-2215 | Abstract | Full text | PDF | |
|
|
|
| Elizabeth A Pehek, Christine Nocjar, Bryan L Roth, Tara A Byrd and Omar S Mabrouk Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex doi:10.1038/sj.npp.1300819 Neuropsychopharmacology 31, 265-277 | Abstract | Full text | PDF | |
|
|
|
| John H Krystal, Aysenil Belger, DCyril D'Souza, Amit Anand, Dennis S Charney, George K Aghajanian and Bita Moghaddam Therapeutic Implications of the Hyperglutamatergic Effects of NMDA Antagonists doi:10.1038/sj.npp.1395426 Neuropsychopharmacology 21, S143-S157 | Abstract | PDF | |
|
|
|
| Mark A Geyer, Kirsten Krebs-Thomson and Geoffrey B Varty The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia doi:10.1038/sj.npp.1395447 Neuropsychopharmacology 21, S134-S142 | Abstract | PDF | |
|
|
|
| Roy Corbett, Lily Zhou, Stephen M Sorensen and Cesare Mondadori Animal Models of Negative Symptoms: M100907 Antagonizes PCP-Induced Immobility in a Forced Swim Test in Mice doi:10.1038/sj.npp.1395452 Neuropsychopharmacology 21, S211-S218 | Abstract | PDF | |
|
|
|
| Michael G Bankson and Kathryn A Cunningham Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity: Role of 5-HT1B/1D and 5-HT2 Receptors doi:10.1016/S0893-133X(01)00345-1 Neuropsychopharmacology 26, 40-52 | Abstract | Full text | PDF | |
|
|
|
| M100907, Schizophrenia |
|
| Geoffrey B Varty, Vaishali P Bakshi, Mark A Geyer and Geoffrey B Varty M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats doi:10.1016/S0893-133X(98)00072-4 Neuropsychopharmacology 20, 311-321 | Abstract | Full text | PDF | |
|
|
|
| Macaca mulatta |
|
| James T Winslow, Pamela L Noble, Casie K Lyons, Sheila M Sterk and Thomas R Insel Rearing Effects on Cerebrospinal Fluid Oxytocin Concentration and Social Buffering in Rhesus Monkeys doi:10.1038/sj.npp.1300128 Neuropsychopharmacology 28, 910-918 | Abstract | Full text | PDF | |
|
|
|
| Gregory C Westergaard, Stephen J Suomi, Tara J Chavanne, Lisa Houser, Anne Hurley, Allison Cleveland, Philip J Snoy and J Dee Higley Physiological Correlates of Aggression and Impulsivity in Free-Ranging Female Primates doi:10.1038/sj.npp.1300171 Neuropsychopharmacology 28, 1045-1055 | Abstract | Full text | PDF | |
|
|
|
| Allison Cleveland, Gregory C Westergaard, Marisa K Trenkle and J Dee Higley Physiological Predictors of Reproductive Outcome and Mother–Infant Behaviors in Captive Rhesus Macaque Females (Macaca mulatta) doi:10.1038/sj.npp.1300361 Neuropsychopharmacology 29, 901-910 | Abstract | Full text | PDF | |
|
|
|
| Stefani N Von Huben, Christopher C Lay, Rebecca D Crean, Sophia A Davis, Simon N Katner and Michael A Taffe Impact of Ambient Temperature on Hyperthermia Induced by (  )3,4-Methylenedioxymethamphetamine in Rhesus Macaquesdoi:10.1038/sj.npp.1301078 Neuropsychopharmacology 32, 673-681 | Abstract | Full text | PDF | |
|
|
|
| Katherine P Weld, Joy A Mench, Ruth A Woodward, Monica S Bolesta, Stephen J Suomi and J Dee Higley Effect of Tryptophan Treatment on Self-Biting and Central Nervous System Serotonin Metabolism in Rhesus Monkeys (Macaca mulatta) doi:10.1038/sj.npp.1395210 Neuropsychopharmacology 19, 314-321 | Abstract | Full text | PDF | |
|
|
|
| Kristin B Zajicek, Cristofer S Price, Susan E Shoaf, Patrick T Mehlman, Stephen J Suomi, Markku Linnoila and J Dee Higley Seasonal Variation in CSF 5-HIAA Concentrations in Male Rhesus Macaques doi:10.1016/S0893-133X(99)00097-4 Neuropsychopharmacology 22, 240-250 | Abstract | Full text | PDF | |
|
|
|
| Macaque |
|
| Jay R Kaplan, Stephen B Manuck, M Babette Fontenot and J John Mann Central Nervous System Monoamine Correlates of Social Dominance in Cynomolgus Monkeys (Macaca fascicularis) doi:10.1016/S0893-133X(01)00344-X Neuropsychopharmacology 26, 431-443 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | |
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
